Highlights

  • Berenberg upgrades Glencore (LSE:GLEN) to Buy following updated production guidance and valuation revisions.
  • UBS downgrades M&G (LSE:MNG) to Neutral, citing shares as fairly valued after recent performance.
  • Broker actions reflect differing sector dynamics across mining and UK life insurance.

Berenberg has updated its view on Glencore Plc (LSE:GLEN), upgrading the stock from Hold to Buy following the company’s Capital Markets Day presentation in December. The revision reflects updated operational guidance and changes to the broker’s valuation assumptions.

The broker incorporated Glencore’s full-year production outlook across commodities including copper, zinc, nickel, cobalt and coal. Copper, in particular, was given greater weight within the valuation framework, reflecting its increasing contribution to the group’s earnings profile.

As part of the review, Berenberg raised its valuation multiple to 6x enterprise value to underlying earnings and lifted its price target to 480p from 350p. The analysis noted that GLEN shares were trading at discounted levels relative to estimated net asset value and forecast 2026 earnings.

Berenberg also flagged that net debt was expected to exceed the company’s previously stated cap by year-end. This, in turn, was seen as a limiting factor for distributions, with the broker modelling only a base cash distribution of USD 0.09 per share. Potential proceeds from asset disposals, including any transaction involving Viterra, were highlighted as variables that could influence capital returns or buy-back activity.

The update followed confirmation that Glencore is continuing with its previously announced share repurchase programme of up to USD 1 billion, with market purchases expected to conclude around the release of 2025 results.

M&G (MNG): UBS Cites Fair Valuation in Downgrade

Separately, UBS has revised its stance on M&G Plc (LSE:MNG), downgrading the stock from Buy to Neutral. The broker stated that the change was driven primarily by valuation considerations rather than a shift in operational expectations.

While the rating was lowered, UBS increased its price target to 290p from 275p, reflecting updated earnings and capital assumptions. The bank indicated that, following recent share price performance, M&G was now trading broadly in line with its assessment of fair value.

UBS also commented on the group’s forecast dividend yield for the 2027 financial year, noting that it appeared lower than some UK-listed peers in the life insurance and asset management space. The firm acknowledged M&G’s solvency position but highlighted that capital strength brings its own considerations around deployment and exposure under stress scenarios.

The note added that M&G shares had outperformed the wider European insurance sector on a year-to-date basis, with the downgrade reflecting relative valuation positioning rather than balance sheet or earnings concerns.

Sector Contrast Through Broker Lenses

Taken together, the broker updates on GLEN and MNG underline contrasting analytical drivers across sectors. In mining, revised production guidance and commodity mix adjustments informed valuation changes, while in insurance, recent share price performance and peer comparison shaped views on relative value.